World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
45029
World Ranking
7285
National Ranking
280

Richard B. Kim publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard B. Kim sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 430 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard B. Kim D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard B. Kim sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard B. Kim is affiliated with the University of Western Ontario in Canada. Their research primarily focuses on the field of Medicine, with specific contributions across several subfields including Oncology, Genetics, Surgery, Epidemiology, and Pediatrics, Perinatology and Child Health.

The scientist's work covers a diverse range of topics, notably:

  • Drug Transport and Resistance Mechanisms
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Pancreatic and Hepatic Oncology Research
  • Pharmacological Effects and Toxicity Studies
  • Immunodeficiency and Autoimmune Disorders
  • Pharmacogenetics and Drug Metabolism

Frequent coauthors collaborating with Richard B. Kim include:

  • Samantha Medwid
  • Ute I. Schwarz
  • Aze Wilson
  • Eric McArthur
  • Flory T. Muanda

Publication venues where this researcher often contributes include:

  • British Journal of Clinical Pharmacology
  • Clinical Pharmacology & Therapeutics
  • Pharmacogenetics and Genomics
  • Scientific Reports
  • Alimentary Pharmacology & Therapeutics

Selected recent papers authored or coauthored by Richard B. Kim are:

  • Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease, 2020, Scientific Reports
  • Impact of pretreatment dihydropyrimidine dehydrogenase genotype-guided fluoropyrimidine dosing on chemotherapy associated adverse events, 2021, Clinical and Translational Science
  • High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists, 2022, Scientific Reports
  • Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report, 2020, Annals of Internal Medicine
  • In Vitro Functional Characterization and in Silico Prediction of Rare Genetic Variation in the Bile Acid and Drug Transporter, Na+-Taurocholate Cotransporting Polypeptide (NTCP, SLC10A1), 2020, Molecular Pharmaceutics

Best Publications

  • Membrane transporters in drug development.

    Kathleen M. Giacomini;Shiew Mei Huang;Donald J. Tweedie;Leslie Z. Benet

  • The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

    R. B. Kim;M. F. Fromm;C. Wandel;B. Leake

  • Identification of functionally variant MDR1 alleles among European Americans and African Americans

    Richard B. Kim;Richard B. Kim;Brenda F. Leake;Brenda F. Leake;Edna F. Choo;Edna F. Choo;George K. Dresser;George K. Dresser

  • Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

    Catia Marzolini;Catia Marzolini;Erik Paus;Erik Paus;Thierry Buclin;Thierry Buclin;Richard B. Kim;Richard B. Kim

  • De novo mutations in histone-modifying genes in congenital heart disease

    Samir Zaidi;Murim Choi;Hiroko Wakimoto;Lijiang Ma

  • SLC transporters as therapeutic targets: emerging opportunities

    Lawrence Lin;Sook Wah Yee;Richard B. Kim;Kathleen M. Giacomini

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies.

    Jason Homsy;Samir Zaidi;Yufeng Shen;James S. Ware;James S. Ware;James S. Ware

  • Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands

    Sheng Chih Jin;Jason Homsy;Samir Zaidi;Qiongshi Lu

  • Genetic determinants of response to warfarin during initial anticoagulation.

    Ute I. Schwarz;Marylyn D. Ritchie;Yuki Bradford;Chun Li

  • Molecular basis of ethnic differences in drug disposition and response.

    H G Xie;R B Kim;A J Wood;C M Stein

  • Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.

    Rommel G. Tirona;Brenda F. Leake;Gracia Merino;Richard B. Kim

  • Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

    George K. Dresser;George K. Dresser;George K. Dresser;David G. Bailey;David G. Bailey;David G. Bailey;Brenda F. Leake;Brenda F. Leake;Brenda F. Leake;Ute I. Schwarz;Ute I. Schwarz;Ute I. Schwarz

  • OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine

    Mirjana Cvetkovic;Brenda Leake;Martin F. Fromm;Grant R. Wilkinson

  • Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and Pharmacogenetics

    Richard H. Ho;Rommel G. Tirona;Brenda F. Leake;Hartmut Glaeser

  • Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

    R. B. Kim;C. Wandel;B. Leake;M. Cvetkovic

  • Transporters and drug therapy: implications for drug disposition and disease.

    Richard H. Ho;Richard B. Kim

  • The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.

    Rommel G Tirona;Wooin Lee;Brenda F Leake;Lu-Bin Lan

  • Inhibition of P-Glycoprotein–Mediated Drug Transport A Unifying Mechanism to Explain the Interaction Between Digoxin and Quinidine

    M F Fromm;R B Kim;C M Stein;G R Wilkinson

  • Pharmacological Inhibition of P-glycoprotein Transport Enhances the Distribution of HIV-1 Protease Inhibitors into Brain and Testes

    Edna F. Choo;Brenda Leake;Christoph Wandel;Hitoshi Imamura

Frequent Co-Authors

Dan M. Roden
Dan M. Roden Vanderbilt University Medical Center
David N. Juurlink
David N. Juurlink University of Toronto
F. Estelle R. Simons
F. Estelle R. Simons University of Manitoba
Gerald L. Mandell
Gerald L. Mandell University of Virginia
Grant R. Wilkinson
Grant R. Wilkinson Vanderbilt University
Alastair J. J. Wood
Alastair J. J. Wood Vanderbilt University
Carl W. Bazil
Carl W. Bazil Columbia University
Jordan W. Smoller
Jordan W. Smoller Harvard University
C. Michael Stein
C. Michael Stein Vanderbilt University Medical Center
Christine E. Seidman
Christine E. Seidman Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring healthcare professionals have more online learning opportunities than ever before. For those looking to enter the administrative side of medicine, a low cost medical coding and billing online program can provide essential skills in managing healthcare records and insurance processes.

Nursing remains a popular career path with many affordable online options. Licensed nurses seeking to advance their qualifications can explore the cheapest rn to bsn online programs, which help RNs earn their Bachelor of Science in Nursing efficiently. For further specialization, becoming a nurse practitioner is a rewarding choice. You can find the cheapest fnp programs online to train as a Family Nurse Practitioner and expand your clinical responsibilities.

For those interested in research, leadership, or academia, a doctorate is often the next step. Several institutions offer the cheapest phd nursing programs via flexible distance learning formats, making advanced education more accessible for working professionals.

Exploring these diverse online programs can help you find an affordable pathway to a fulfilling career in the healthcare field.

Best Scientists Citing Richard B. Kim

Trending Scientists

Recently Published Articles